CAPUCCI, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 7.927
EU - Europa 4.712
AS - Asia 3.507
SA - Sud America 926
AF - Africa 341
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 8
Totale 17.436
Nazione #
US - Stati Uniti d'America 7.795
RU - Federazione Russa 1.384
SG - Singapore 1.159
VN - Vietnam 838
BR - Brasile 731
UA - Ucraina 678
CN - Cina 523
IT - Italia 467
DE - Germania 440
IE - Irlanda 400
SE - Svezia 299
FR - Francia 257
HK - Hong Kong 244
DK - Danimarca 220
TR - Turchia 197
GB - Regno Unito 184
FI - Finlandia 178
MA - Marocco 150
KR - Corea 119
IN - India 102
CI - Costa d'Avorio 99
AR - Argentina 67
BD - Bangladesh 65
CA - Canada 57
MX - Messico 47
NL - Olanda 46
IQ - Iraq 40
JP - Giappone 38
ZA - Sudafrica 35
EC - Ecuador 33
ES - Italia 31
PL - Polonia 31
CO - Colombia 26
ID - Indonesia 25
PK - Pakistan 24
VE - Venezuela 20
AT - Austria 19
BE - Belgio 19
TN - Tunisia 15
UZ - Uzbekistan 15
CL - Cile 13
JO - Giordania 13
EG - Egitto 12
EU - Europa 12
TH - Thailandia 12
CZ - Repubblica Ceca 11
KZ - Kazakistan 11
PE - Perù 11
PH - Filippine 11
RS - Serbia 11
SA - Arabia Saudita 11
PY - Paraguay 10
MY - Malesia 9
RO - Romania 9
AE - Emirati Arabi Uniti 8
CR - Costa Rica 8
UY - Uruguay 8
ET - Etiopia 7
BO - Bolivia 6
DO - Repubblica Dominicana 6
DZ - Algeria 6
SN - Senegal 6
AU - Australia 5
LB - Libano 5
NP - Nepal 5
BH - Bahrain 4
IL - Israele 4
KE - Kenya 4
LT - Lituania 4
AZ - Azerbaigian 3
BG - Bulgaria 3
HU - Ungheria 3
KG - Kirghizistan 3
NZ - Nuova Zelanda 3
OM - Oman 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
XK - ???statistics.table.value.countryCode.XK??? 3
AL - Albania 2
AO - Angola 2
GE - Georgia 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
JM - Giamaica 2
KH - Cambogia 2
KW - Kuwait 2
NI - Nicaragua 2
NO - Norvegia 2
PA - Panama 2
PR - Porto Rico 2
SY - Repubblica araba siriana 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
BZ - Belize 1
CD - Congo 1
Totale 17.424
Città #
Ashburn 1.036
Singapore 744
Jacksonville 711
Chandler 664
Fairfield 556
Dublin 395
Boardman 376
Dallas 328
New York 310
San Jose 269
Ho Chi Minh City 260
Wilmington 245
Hong Kong 235
Seattle 213
Woodbridge 212
Houston 202
Hanoi 195
Cambridge 182
The Dalles 172
Beijing 151
Lawrence 149
Princeton 149
San Mateo 144
Lauterbourg 142
Los Angeles 127
Ann Arbor 115
Abidjan 99
Moscow 94
Hefei 90
Des Moines 84
Munich 75
San Diego 73
São Paulo 65
Turin 53
London 49
Chicago 45
Ancona 44
Da Nang 44
Centro 40
Buffalo 39
Haiphong 34
Helsinki 34
Turku 34
Santa Clara 33
Council Bluffs 32
Frankfurt am Main 32
Orem 32
Pune 31
Tokyo 31
Warsaw 26
Belo Horizonte 24
Amsterdam 23
Rio de Janeiro 23
Montreal 21
Norwalk 21
Brasília 20
Chennai 20
Denver 20
Salt Lake City 20
Washington 20
Atlanta 19
Hải Dương 19
Brussels 18
Johannesburg 18
Nuremberg 18
Baghdad 16
Phoenix 16
Poplar 16
Stockholm 16
Salvador 15
Guangzhou 14
Mumbai 14
Porto 14
Shanghai 14
Amman 13
Tashkent 13
Brooklyn 12
Biên Hòa 11
Guayaquil 11
Manchester 11
Mexico City 11
Quảng Ngãi 11
Redmond 11
Rome 11
Toronto 11
Vienna 11
Campinas 10
Can Tho 10
Curitiba 10
Lahore 10
Milan 10
Tampa 10
Belgrade 9
Bogotá 9
Cape Town 9
Elk Grove Village 9
Olomouc 9
Porto Alegre 9
Quận Ba 9
Tunis 9
Totale 10.203
Nome #
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 836
Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. 232
Assessment of the German and Italian Stress Cardiomyopathy Score for Risk Stratification for In-hospital Complications in Patients with Takotsubo Syndrome 226
Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on a Tertiary-Level Electrophysiology Laboratory in Italy 182
Global longitudinal strain measured by speckle tracking identifies subclinical heart involvement in patients with systemic sclerosis 164
Flecainide: Electrophysiological properties, clinical indications, and practical aspects 155
Incidence and risk of cardiotoxicity in cancer patients treated with targeted therapies 152
An Unusual Left Atrial Mass in a Woman with Active Breast Cancer and Recent Cardiothoracic Surgery 150
Tachycardiomyopathy in Patients without Underlying Structural Heart Disease 149
Procedural sedation for direct current cardioversion: a feasibility study between two management strategies in the emergency department 148
Atrial tachyarrhythmia recurrence temporal patterns in bradycardia patients implanted with antitachycardia pacemakers. 143
Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists 141
'Patient choice' concept in AF ESC Guidelines: is the clinician giving up? 141
Dronedarone: a real innovation or a mere second-best choice? How to find the way among guidelines, regulatory agencies and daily clinical practice 141
Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients with Atrial Fibrillation: A Report from the GARFIELD-AF Registry 137
Anti-arrhythmic drugs in atrial fibrillation: tailor-made treatments 136
Impact of atrial fibrillation in critically ill patients admitted to a stepdown unit 135
Amiodarone and digitalis: An odd couple in a tachycardiomyopathic patient 135
Long-Term Implications of Atrial Fibrillation in Patients With Degenerative Mitral Regurgitation 135
CHA2DS2-VASc risk factors as predictors of stroke after acute coronary syndrome: A systematic review and meta-analysis 134
Subclinical Cardiac Dysfunction in Polymyositis and Dermatomyositis: A Speckle-tracking Case-control Study 133
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry 132
A New Electrocardiographic Marker of Sudden Death in Brugada Syndrome: The S-Wave in Lead I 131
Cardioembolism and takotsubo syndrome: A case report 130
New anthyarrhythmic drugs for atrial fibrillation 129
Comorbidities frequency in takotsubo syndrome: An international collaborative systematic review including 1109 patients 129
Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. 128
Cardiac resynchronization therapy and electrical storm: results of the OBSERVational registry on long-term outcome of ICD patients (OBSERVO-ICD) 128
Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events. 127
A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation. 126
Dr. Guerra, et al reply 125
Incidence and Clinical Impact of Recurrent Takotsubo Syndrome: Results From the GEIST Registry 125
Coronary Spasm and Inflammation: Can We Kill 2 Birds With 1 Stone? 124
Takotsubo syndrome in the paediatric population: A case report and a systematic review 123
Implantable cardioverter-defibrillator programming and electrical storm: Results of the OBSERVational registry On long-term outcome of ICD patients (OBSERVO-ICD) 121
Atrial overdriving is beneficial in patients with atrial arrhythmias: first results of the PROVE Study. 118
Letter by Ciliberti and Capucci regarding article, "medical therapy for secondary prevention and long-term outcome in patients with myocardial infarction with nonobstructive coronary artery disease" 117
Temporal relationship between subclinical atrial fibrillation and embolic events 117
Clinically guided pacemaker choice and setting: pacemaker expert programming study 116
Subclinical progression of systemic sclerosis-related cardiomyopathy 115
ASymptomatic atrial fibrillation and Stroke Evaluation in pacemaker patients and the atrial fibrillation Reduction atrial pacing Trial (ASSERT). 115
[Early and mid-term results of the transapical aortic valve Symetis Acurate TA: a viable solution in high-risk patients with severe vascular disease] 115
Antiarrhythmic drugs for atrial fibrillation. 115
Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fibrillation: data from the Euro Heart Survey. 114
Current Therapeutic Options for Heart Failure in Elderly Patients 114
Subclinical atrial fibrillation and the risk of stroke 113
Global Longitudinal Strain as a Predictor of First and Subsequent Arrhythmic Events in Remotely Monitored ICD Patients With Structural Heart Disease 113
Pharmacological therapy for the prevention of cardiovascular events in patients with myocardial infarction with non-obstructed coronary arteries (MINOCA): Insights from a multicentre national registry 113
Prospective Study of Tricuspid Regurgitation Associated With Permanent Leads After Cardiac Rhythm Device Implantation 112
Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillation. 111
Ranolazine for rhythm control in atrial fibrillation: A systematic review and meta-analysis 111
Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF 110
Cardiomyopathy induced by frequent premature ventricular complexes originating from the right ventricular outflow tract: left ventricular systolic function recovery after transcatheter ablation. 110
Atrial Fibrillation and Congestive Heart Failure: should we aim to control the heart's rate or its rhythm? 110
Atrial fibrillation requiring urgent medical care. Approach and outcome in the various departments of admission. Data from the atrial Fibrillation/flutter Italian REgistry (FIRE). 110
IntErnationaL eLeCTRicAl storm registry (ELECTRA): Background, rationale, study design, and expected results 110
Is there an 'atherosclerotic continuum' from angina with unobstructed coronary arteries to MINOCA? 110
Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation. 110
Compassionate drug use for patients with transthyretin amyloid cardiomyopathy 110
Quality of vitamin k antagonist control and 1-year outcomes in patients with atrial fibrillation: A global perspective from the GARFIELD-AF registry 110
The ECG in the differential diagnosis between takotsubo cardiomyopathy and acute coronary syndrome 109
Flecainide-metoprolol combination reduces atrial fibrillation clinical recurrences and improves tolerability at 1-year follow-up in persistent symptomatic atrial fibrillation 109
A multicentre, double-blind randomized crossover comparative study on the efficacy and safety of dofetilide vs sotalol in patients with inducible sustained ventricular tachycardia and ischaemic heart disease. 107
Reproducibility of internal atrial defibrillation threshold in paroxysmal and persistent atrial fibrillation. 106
Transient QRS amplitude attenuation is associated with clinical recovery in patients with takotsubo cardiomyopathy 106
New insights into the initiation of atrial fibrillation: a detailed intraindividual and interindividual analysis of the spontaneous onset of atrial fibrillation using new diagnostic pacemaker features. 104
Hospitalization in ICD recipients. 104
Feasibility of a cardiologist-only approach to sedation for electrical cardioversion of atrial fibrillation: A randomized, open-blinded, prospective study 104
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 104
Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation. 103
The role of EP-guided therapy in ventricular arrhythmias: beta-blockers, sotalol, and ICD's. 102
Out-of-hospital cardiac arrest and public access defibrillation. 102
Left intraventricular myocardial deformation dyssynchrony identifies responders to cardiac resynchronization therapy in patients with heart failure. 102
Capture of atrial fibrillation reduces the atrial defibrillation threshold. 101
Efficacy and Safety of Dronedarone in Patients Previously Treated With Other Antiarrhythmic Agents 101
Muscle ergoreceptor overactivity reflects deterioration in clinical status and cardiorespiratory reflex control in chronic heart failure. 100
Cardiac resynchronization therapy improves ejection fraction and cardiac remodelling regardless of patients' age 100
Community-based automated external defibrillator only resuscitation for out-of-hospital cardiac arrest patients 100
Endocardial defibrillation lead extraction: an unusual case of entrapment. 99
Bone marrow cell transplantation improves cardiac, autonomic, and functional indexes in acute anterior myocardial infarction patients (Cardiac Study). 99
Temporal trends and temperature-related incidence of electrical storm: The TEMPEST Study (Temperature-related incidence of electrical storm) 99
Is invasive coronary provocation testing cost-effective among MINOCA patients? 99
Memorizzazione a distanza dei contenuti teorici derivati dai corsi BLS e BLS-D 99
Prospective evaluation of the multisensor HeartLogic algorithm for heart failure monitoring 99
Indications for implantable cardioverter defibrillator (ICD) therapy. 98
Intravenous vernakalant for the rapid conversion of recent onset atrial fibrillation: systematic review and meta-analysis 98
Omega-3 PUFAs and Atrial Fibrillation: Have We Made Up Our Mind Yet? 98
Racial and Ethnic Differences in Electrocardiographic Features of Takotsubo Cardiomyopathy 98
Sedation in cardiac arrhythmias management 98
Interactions between Atrial Fibrillation, Cardiovascular Risk Factors, and ApoE Genotype in Promoting Cognitive Decline in Patients with Alzheimer's Disease: A Prospective Cohort Study 98
Electrical storm and heart failure worsening in implantable cardiac defibrillator patients 97
Rebuttal of critique of Progetto Vita survival data 97
Emerging pharmacotherapies for the treatment of atrial fibrillation 97
Entirely Subcutaneous Implantable Defibrillator: Safest Option in a Young Girl With Ventricular Tachycardia and Ebstein Anomaly 97
Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: The ALPHEE study 96
Influence of left atrial enlargement and body weight on the development of atrial fibrillation: retrospective study on 205 dogs. 96
Role of electrical storm as a mortality and morbidity risk factor and its clinical predictors: a meta-analysis 95
Symptomatic atrial fibrillation and risk of cardiovascular events: Data from the Euro Heart Survey 95
ESC-ERC recommendations for the use of automated external defibrillators (AEDs) in Europe. 94
Effects of diltiazem pretreatment on direct-current cardioversion in patients with persistent atrial fibrillation: a single-blind, randomized, controlled study. 94
Totale 12.506
Categoria #
all - tutte 86.371
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.371


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021484 0 0 0 0 0 0 0 0 0 184 208 92
2021/20221.106 89 287 33 25 28 48 73 68 66 71 121 197
2022/20232.113 175 223 146 168 161 281 7 106 469 46 254 77
2023/20241.346 254 48 97 186 233 297 18 36 12 24 15 126
2024/20252.382 191 330 104 18 74 61 128 94 579 167 263 373
2025/20266.690 458 389 385 868 632 442 1.155 703 1.140 518 0 0
Totale 17.667